Literature DB >> 11254691

Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.

E Y Choi1, Y Yoshimura, G J Christianson, T J Sproule, S Malarkannan, N Shastri, S Joyce, D C Roopenian.   

Abstract

Minor histocompatibility Ags (minor H Ags) are substantial impediments to MHC-matched solid tissue and bone marrow transplantation. From an antigenic standpoint, transplantation between MHC-matched individuals has the potential to be remarkably complex. To determine the extent to which the immune response is simplified by the phenomenon of immunodominance, we used peptide/MHC tetramers based on recently discovered minor H Ags (H60, H13, and HY) and monitored in vivo CD8 T cell responses of female C57BL/6 mice primed with MHC-matched, but background-disparate, male BALB.B cells. CD8 T cells against H60 overwhelmed responses to the H13 and HY throughout primary and secondary challenge. H60 immunodominance was an inherent quality, overcoming a lower memory precursor frequency compared with that of H13 and evoking a T cell response with diverse TCRV beta usage. IFN-gamma staining examining congenically defined minor H Ags extended H60 dominance over additional minor H Ags, H28, H4, and H7. These four minor H Ags accounted for up to 85% of the CD8 T cell response, but H60 stood out as the major contributor. These findings show that immunodominance applies to antigenically complex transplantation settings in vivo and that the responses to the H60 minor H Ag dominates in this model. We suggest that immunodominant minor H Ags are those that result from the absence of a self analog.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254691     DOI: 10.4049/jimmunol.166.7.4370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen.

Authors:  Brianna Luedtke; Laura M Pooler; Eun Young Choi; Angela M Tranchita; Corbett J A Reinbold; Aaron C Brown; Daniel J Shaffer; Derry C Roopenian; Subramaniam Malarkannan
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

3.  Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

Authors:  Barry J Kappel; Javier Pinilla-Ibarz; Adam A Kochman; Jeffrey M Eng; Vanessa M Hubbard; Ingrid Leiner; Eric G Pamer; Glen Heller; Marcel R M van den Brink; David A Scheinberg
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT.

Authors:  Alwi M Shatry; Derry C Roopenian; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

5.  Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.

Authors:  Ling Weng; Julian Dyson; Francesco Dazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

Review 6.  Special regulatory T-cell review: Regulation of immune responses--examining the role of T cells.

Authors:  Elizabeth Simpson
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

7.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

8.  A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment.

Authors:  Su Jeong Ryu; Ji Yeong Jeon; Jun Chang; Thomas J Sproule; Derry C Roopenian; Eun Young Choi
Journal:  Mol Cells       Date:  2012-03-21       Impact factor: 5.034

9.  DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.

Authors:  He Zhou; Yunping Luo; Jeng-fan Lo; Charles D Kaplan; Masato Mizutani; Noriko Mizutani; Jiing-Dwan Lee; F James Primus; Jürgen C Becker; Rong Xiang; Ralph A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

10.  In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation.

Authors:  Alwi Shatry; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2009-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.